HOME › DRUGS › BUDESONIDE;FORMOTEROL
ACTIVE SUBSTANCE / INN

BUDESONIDE;FORMOTEROL

Brand name(s): BiResp Spiromax, Vylaer Spiromax, DuoResp Spiromax, Budesonide/Formoterol Teva
EMA LISTED
WITHDRAWN
AUTHORISED
Pulmonary Disease, Chronic Obstructive;Asthma
ACTIVE SUBSTANCE
Budesonide;Formoterol
REGULATORS
EMA
SPONSORS / MAH
Teva Pharma B.V.
TOTAL APPLICATIONS
4
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
DuoResp SpiromaxTeva Pharma B.V.Authorised28/04/2014Pulmonary Disease, Chronic Obstructive;Asthma
BiResp SpiromaxTeva Pharma B.V.Authorised28/04/2014Pulmonary Disease, Chronic Obstructive;Asthma
Budesonide/Formoterol TevaTeva Pharma B.V.Withdrawn19/11/2014Pulmonary Disease, Chronic Obstructive;Asthma
Vylaer SpiromaxTeva Pharma B.V.Withdrawn19/11/2014Pulmonary Disease, Chronic Obstructive;Asthma

FULL INTELLIGENCE ON BUDESONIDE;FORMOTEROL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →